Bio-Rad Laboratories BIO EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Bio-Rad Laboratories’s reported figures.
The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories's EBITDA?
- Bio-Rad Laboratories (BIO) reported EBITDA of $80.9M in Q1 2026.
- How has Bio-Rad Laboratories's EBITDA changed year-over-year?
- Bio-Rad Laboratories's EBITDA increased by 21.1% year-over-year, from $66.8M to $80.9M.
- What does EBITDA mean?
- Operating cash profit before interest, taxes, and non-cash charges.
- How do you interpret EBITDA?
- Higher is better and widely used to value capital-intensive businesses, but it ignores the real cost of capex — pair it with free cash flow. (Defined as EBIT + D&A so EBITDA = EBIT + D&A holds exactly.)
- How does EBITDA compare across companies?
- Standard cross-company operating-profit proxy for non-financials; not meaningful for banks and insurers.